Concepedia

Publication | Open Access

Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes

139

Citations

30

References

2008

Year

Abstract

Targeting CD22 depletes and reprograms B-cells and reverses autoimmune diabetes, thereby providing a blueprint for development of novel therapies to cure autoimmune diabetes.

References

YearCitations

Page 1